← ANALYSTS · TIPRANKS

Charles Moore · Robert W. Baird

#5625among 12,504 TipRanks analysts★★★★★★★★★★
Hits 71% 5 of 7 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +14.1% Over a year after the rating, TipRanks’ measure
Our companies rated now 3 Buy / hold / sell: 2 / 1 / 0
Upside of the analyst’s targets +112.1% Average over 3 current targets, to the last price
The market’s answer to the ratings +2.8% Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 13on TipRanks Oct 14 05:55 CTNMIWMContineum Therapeutics, Inc. Class A · $297M Downgrade Hold $19.00 → $14.00−26.3% +97.7% −1.7%next day −2.2%
Aug 7on TipRanks 08:01 DNLIIWMDenali Therapeutics · $2.9B Reiterated Buy $31.00 → $34.00+9.7% +93.1% −0.2%next day +0.7% · 5 days −2.1%
Feb 13on TipRanks 09:25 DRUGIWMBright Minds Biosciences · $535M Reiterated Buy $142 → $126−11.3% +145.6% −3.4%next day +7.6% · 5 days +10.9%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗